Press Releases

12 December 2019
New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score to Guide Chemotherapy Treatment in Young Patients with Node-negative or Node-positive Early-stage Breast Cancer

2 October 2019
New TAILORx Data, Published in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score Test to Guide Chemotherapy Treatment

21 June 2019
German Federal Joint Committee (G-BA) Issues Exclusive Nationwide Reimbursement Decision for Oncotype DX Breast Recurrence Score Test

4 June 2019
Secondary Analysis of Landmark TAILORx Results, Published in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score Test to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision

25 March 2019
Evidence from UK Hospitals Supports the Value of the Oncotype DX Test in Avoiding Unnecessary Chemotherapy for Patients with Node-positive Breast Cancer

Media Coverage

20 December 2019
Gene Tests to Help Breast Cancer Patients

16 October 2019
Do I Need Chemotherapy?

3 September 2019
Genomic Testing Helps Women to Tailor Their Breast Cancer Care

31 July 2019
Scottish Government to Respond to NHS Tayside Chemo Criticism in Coming Weeks

30 April 2019
Top Doctors to Help with Cancer Review at NHS Tayside

17 April 2019
NHS Tayside Chemotherapy Treatment Probe Calls for Review of Decision Making Across Health Board

23 March 2019
5,000 Breast Cancer Sufferers Could be Spared Chemotherapy if Offered Gene Testing, Study Suggests

27 February 2019
Understanding the Patient as Well as the Disease Is the Only Way to Make the NHS More Sustainable

You are now leaving this site.

Any third-party link you select from this site may take you to an Exact Sciences website intended for US audiences or a website that is not affiliated with Exact Sciences.

I agree